BVAXF News and Press, BioVaxys Technology Corp. From 04/22/25

2025-04-22 15:15:00 ET BioVaxys (CSE: BIOV) (OTCQB:BVAXF) (FRA: 5LB) and SpayVac-for-Wildlife announced an expansion of the fields of use in the current license agreement to include commercial aquaculture and the farm-raised fish market. With this expansion, SpayVac’s markets now...

BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture Canada NewsWire Submission Process Underway for Regulatory Approval of SpayVac in Feral Horses and Free-Ranging Deer Populations VANCOUVER, BC and MADISON, Wis. , April...

BioVaxys Technology Corp. Granted Management Cease Trade Order Canada NewsWire VANCOUVER, BC , March 3, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys " or " Company ") announces that, further to its news release...

2025-02-28 09:10:00 ET February 28, 2025 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks added to the biotech stock directory. The newest biotechnology companies are focused on pain alleviation,...

BioVaxys Announces Application for Management Cease Trade Order Canada NewsWire - Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC , Feb. 13, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (" BioVaxys...

BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030* Canada NewsWire VANCOUVER, BC , Jan. 16, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or ...